Could Hims & Hers Stock Fall 63% Again?
Today’s big story: Could Anthropic Stock Fall 25%?
Shares of Hims & Hers Health (HIMS) lost 41.6% in the month to November 18, 2026, while the S&P 500 fell 5.0%. Shareholders have already taken a deep loss, and the wider market has started to slip too. So when the whole market has sold off before, how far did Hims & Hers stock fall, and how long did it take to get back?

How Far Has Hims & Hers Stock Fallen Before?
In the 2025 US Tariff Shock, Hims & Hers stock fell 63.1%, while the S&P 500 fell 19.0%. That was its deepest fall in the five market sell-offs it has traded through. Across all five, the stock fell 37.0% on average, against 13.4% for the index.
In the 2025 sell-off, Hims & Hers stock lost nearly two-thirds of its value. If a large part of your savings sits in this one stock, a drop like that would be hard to live through. In a free 30-minute review, our partner advisory firm can show you ways to limit your loss if the stock falls further and to sell with a smaller tax bill. Book the free review.
Four of those five falls were made up. From its lowest close, the stock took a median of 2.6 months to get back to the high it fell from during the sell-off. The longest wait was 8.1 months, after the 2023 SVB Regional Banking Crisis. The 2025 fall has not been made up. The latest close is 75.2% below the stock’s February 2025 peak. That is lower than at any point in the sell-off window, which ran from February to June 2025.
Sales Keep Growing, But Hims & Hers Loses Money
Hims & Hers recorded sales of $2.87 billion in the twelve months to September 2026, up 29.8% from a year earlier. That pace marked a slowdown from the 78.0% growth recorded in the twelve months before. Within that period, growth has re-accelerated. Sales in the third quarter of 2026 alone rose 48.6% from a year earlier.
Profit has moved in the opposite direction. Over the past twelve months, the company posted an operating loss equal to 8.1% of sales, following a 5.2% operating margin a year earlier. Gross margin, the portion of sales remaining after product costs, fell to 63.8% from 75.0% a year earlier. Two years earlier, that figure stood at 81.1%.
The company has also taken on additional debt. Its debt reached $1.56 billion at the end of September 2026, climbing from $1.12 billion a year earlier. Against that, Hims & Hers held $712 million of cash and short-term investments.
What Is Getting Worse At Hims & Hers Now?
On November 9, 2026, management lowered its profit outlook for the year. The company now expects 2026 adjusted EBITDA of $267 million at the midpoint. Adjusted EBITDA is its own measure of profit before interest, taxes and some other costs. In August it had expected $300 million. The company tied the cut to more aggressive pricing and marketing moves it expects to make in the U.K. and Germany. It also pointed to weight loss membership revenue it has deferred.
The subscriber count is also falling. Hims & Hers ended the third quarter with 2.8 million subscribers, which was 100,000 fewer than three months earlier. The company plans to keep marketing spend down in its U.S. weight loss specialty during the fourth quarter. It said that may mean another quarter of weaker subscriber numbers.
Hims & Hers is expected to report its fourth-quarter results in February 2027. That release will reveal the subscriber count following another quarter of lower marketing spend.
Hims & Hers stock has fallen further than the S&P 500 in all five sell-offs it has traded through.
Could You Hold On Through The Next Fall?
Holding on is easier when your portfolio falls less than the market. For every dollar its benchmark lost, the Trefis High Quality (HQ) Portfolio lost about 81 cents on average, holding 30 quality stocks in equal weight.
Spot an error or want more like this? Tell us in 10 seconds.